INDICATORS OF AMINO ACIDS AGAINST THE BACKGROUND OF TAKING BISPHOSPHONATE GROUP DRUGS IN PATIENTS WITH INFLAMMATORY DISEASES OF THE MAXILLOFACIAL REGION bisphosphonate-related osteonecrosis of the jaw, amino acids, nephrotoxicity, bisphosphonates; intravenous administration; zoledronic acid; zoledronate; ibandronate Kh. Ordashev, М. Loktionovа, V. Sletova, V. Vintaev, A. Khatagov, А. Sletov, А. Shahbanov https://doi.org/10.54890/1694-6405